ABSTRACT Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the deposition of extracellular senile plaques composed of amyloid ,B-peptide (AP3). Whereas most cases of AD occur sporadically, about 10% of AD cases are inherited as a fully penetrant autosomal dominant trait. Mutations in the recently cloned Presenilin genes (PS-1 and PS-2) are by far the most common cause of early onset familial AD. Materials and Methods: Cellular expression of endogenous and overexpressed PS proteins was analyzed by immunocytochemistry and metabolic labeling followed by immunoprecipitation. In vivo phosphorylation sites of PS proteins were analyzed by extensive mutagenesis. Results: PS-1 as well as PS-2 proteins were localized predominantly within the endoplasmic reticulum (ER).
INTRODUCTION
Alzheimer's disease (AD) is the most common form of dementia. AD is characterized by the massive and invariable accumulation of senile plaques in certain regions of the brain (1) . The degree of the dementia appears to correlate to some extent with the size of cortical area affected by AP3 depositions, suggesting a causal role of A,B in AD (2) . Senile plaques are predominantly composed of amyloid ,B-peptide (A3), a proteolytic product of the ,B-amyloid precursor protein (/3APP) (1, 3, 4) .
Most of the AD cases appear to occur sporadically, however in approximately 10% of the cases the disease can be inherited as an autosomal dominant trait resulting in early onset familial Alzheimer's disease (FAD) . FAD was mapped so far to at least three different loci, localized on human chromosomes 1, 14, and 21 (5) (6) (7) (8) (9) . In addition, a polymorphism in a gene encoding apolipoprotein E has been shown to decrease the age of onset of AD and to increase the risk for the disease (10) . The gene on chromosome 21 turned out to be the 13APP gene. To date, five different AD-linked mutations were found within the ,BAPP gene (11) . These mutations are localized close to the cleavage sites of ,3APP processing enzymes ( 12) . All of these mutations were shown to influence the processing of 13APP in a pathological manner, by either increasing the total amount of secreted AP3 or by producing A,B peptides with elongated C termini (13) (14) (15) (16) . However, mutations in the ,3APP gene account for only a very small minority of FAD cases.
In contrast, genes belonging to the Presenilin (PS) gene family were found to be involved in about 40-50% of the early onset FAD cases. Two homologous genes, PS-1 and PS-2, located on human chromosome 14 (PS-1) and human chromosome 1 (PS-2), respectively, were cloned recently (9, (17) (18) (19) . The PS genes encode proteins which are 64% homologous and might adopt a potential seven transmembrane domain structure ( Fig. la) (18) (19) (20) . Within the PS-1 gene at least 30 different mutations have been identified so far, while only two mutations were localized to the PS-2 gene (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . All mutations occur at positions which are conserved in both PS genes and seem to cluster within the putative transmembrane domain 2 (TM2) and the large hydrophilic loop between TM6 and TM7 indicating important functional properties of these domains (20) . Depending on the mutation, they can cause onset of AD between the age of 25 and 85 years (17) (18) (19) (21) (22) (23) (24) (25) (26) (27) (28) . This finding clearly indicates that the mutations can have mild or severe effects on the biological function or pathological misfunction of PS proteins. The PS genes are transcribed in a variety of different tissues and are not brain specific (17) (18) (19) 29) . However, within the human brain PS-1 as well as PS-2 transcripts are expressed in regions that are affected most severely during the disease (29, 30) . Although the physiological function of the PS proteins is unknown, sequence homologies to the Caenorhabditis elegans genes spe-4 and sel-12 suggest a potential role of the PS proteins in either vesicular sorting and trafficking or in notch signaling (31, 32) . Recent experiments analyzing the expression of recombinant PS-2 cDNAs in transfected cells revealed that flagged PS-2 proteins are expressed as membrane bound -45-kD proteins and might be located within an intra-membranous network, perhaps the endoplasmic reticulum (ER) (29) . Here, we report on the cellular localization and posttranslational modifications of PS-I as well as PS-2 proteins.
MATERIALS AND METHODS
In Vitro Mutagenesis and Transfection C-terminal deletions of the PS-2 protein were constructed by introducing stop codons after the putative transmembrane domains (TM) 7, 6, 5, and 4 using PCR. The following oligonucleotide was used as a forward primer: 5'-CCGAATTCCAAGTGTCC GGGATT-3' (PS2forward). The following oligonucleotides were used as a reverse primer: 5'-CC GGATC C CTACTTCTTGAACACAGC -3' (PS2TM7stop), 5 '-CCGGATCCCTACCClTTGGG A CACAG-3' (PS2TM6stop), 5'-CCGGATCCCTAGT ACTTGATGAACAC-3' (PS2TM5stop), 5'-CCGG GATCCCTACCAGTGGATGCACAC -3' (PS2TM4-stop). The forward primer contained an EcoRI restriction site, and the reverse primer a BamHI restriction site and a STOP codon. After PCR using the wt PS-2 cDNA as a template, the isolated products were restricted with BamHI and EcoRI and cloned into the expression vector pSG5 (Stratagene, La Jolla, CA, U.S.A.). The deletions were confirmed by DNA sequencing. The corresponding PS-1 constructs were generated using the same strategy.
Construction of the hybrid molecules (PS- TCTTlTGTC-3' (PS-1 TMIforward) and 5'-CCG  GATCCGCAAATATGCTAGAT-3' (PS-1 1660 reverse) . The PCR product was restricted with BamHI and EcoRI and subcloned into pSG5. The PS-2 N terminus was amplified using the following primers: 5'-CCGAATTCCCAAGTGTC CGGGATT-3' (PS-2 N' forward) and 5'-CCGAA TTCCGCTCCGTATTTGAGGGTCAG-3' (PS-2 N' reverse). The PCR fragment was restricted by EcoRI and subcloned into the above described pSG5 containing the PS-1 sequence. The EcoRI site creates two additional amino acids (Glu, Phe); however, these amino acids cannot be phosphorylated. The orientation of the subcloned EcoRI fragment was analyzed by PCR using the primers PS-2 N' forward and PS-1 1660 reverse. The second hybrid construct was generated using the same strategy. The following primers were used to amplify the PS-I N terminus: 5'-CCGAATTC GGCGCCATATTTCAATGT-3' (PS-1 N' reverse), 5' -CCGAATTCAAGAAAGAACCTCAA-3' (PS-1 187 forward). The following primers were used to amplify the PS-2 sequence between TM1 and the stop codon: 5'-CCGGATCCACACCATGTCC CTCA-3' (PS-2 1700 reverse), 5'-CCGAATTCAA GCACGTGATCATGCTG-3' (PS-2 TM1 forward). The double serine mutations at position 7 and 9 of PS-2 were generated by PCR using the following forward primer: 5' -CCGAATTCCTTCC AGAGGCAGGGCTATGCTCACATTCATGGCCG CCGACGCCGAGGAA-3' (PS-2Ser7,9Ala forward) and the PS-2 1700 reverse primer (see above). The construct was subcloned into the EcoRI and BamHI restriction sites of pSG5. The mutations were confirmed by DNA sequencing.
The PS-2Aas (acidic stretch) cDNA construct was generated by PCR using the following primers: 5'-CCGAATTCCTTCCAGAGGCAGGGCTAT GTCGGCCGAGAGC-3' (PS-2Aas forward) and PS-2 1700 reverse (see above). The PCR products were cloned into the EcoRI and BamHI restriction sites of pSG5.
PS-2 GST fusion proteins were generated as follows: A fusion protein of glutathione S-transferase (GST) and the N terminus of PS-2 was constructed by using the primers 5'-CCGGATC CCTCACATTCATGGCC-3' and 5' -TGCGGTCGA CGTGCTTCGCTCCGTA-3' to generate the coding region of the PS-2 N terminus with PCR. The fragments were inserted in the EcoRI/SalI sites of pGEX-4T- 1 Fig. 1 B and C) . fBAPP from cell lysates was imrnunoprecipitated using antibody C7 raised to its 20 C-terminal amino acids (33) and secreted APPS from conditioned media was immnunoprecipitated with antibody B5 (15) . The monoclonal antibodies 5A3/ 1G7 (35) Fig. 1 B and C, PS-1 as well as PS-2 were expressed as proteins with an apparent molecu-lar weight of approximately 45 kD. As expected from sequence homologies between PS-1 and PS-2, antibodies TOR519 and BOS4627 specifically immunoprecipitate both proteins, whereas antibody BOS4624 exclusively identifies PS-1 ( Fig. 1 B and C) . No reactivity was observed in mock transfected cells using antibody TOR519 (Fig. 1 B) . In addition to these low-molecular weight proteins, proteins of -90 kD were found. After longer exposure, 140-kD proteins are also observed. This observation suggests that PS proteins might form dimeric and trimeric aggregates. The high-molecular weight bands of the PS proteins are indeed aggregates and not coprecipitating or nonspecifically precipitated proteins as shown by an expected shift of the predicted molecular weight of these multimeric species in cells expressing various C-terminally truncated PS-I proteins terminating after TM7, TM6, TM5, and TM4 ( Fig. ID; for details, see below). However, it is not clear yet if these multimeric forms occur in vivo or are a result of the extraction procedure (see discussion).
Sequential deletion of the C terminus removes the epitopes of the corresponding antibody, and results in the failure to detect these proteins. The N-terminal antibody TOR5 19 identifies all deletions (Fig. 1D ), whereas the loopspecific antibody BOS4624 identifies full-length and TM7-deleted PS-1 but not the truncated PS-1 protein terminating after TM6 (Fig. 1E) . Moreover, the C-terminal antibody BOS4627 immunoprecipitates full-length PS-1 only, and none of the deleted PS proteins are recognized (Fig. lE) . Therefore, these results clearly demonstrate the specificity of the antibodies used and show that both antibodies, TOR5 19 and BOS4627 can be used for specific detection of PS-1 and PS-2, whereas antibody BOS4624 detects exclusively PS-I proteins.
Subcellular Localization of PS Proteins
To investigate the subcellular localization of endogenous PS proteins, confocal laser scanning microscopy was carried out. Untransfected CHO cells were stained with the affinity-purified antibody TOR519. A diffuse staining throughout the cytoplasm was detected ( Fig. 2A) . Since the staining pattern suggested that PS proteins might be located within the ER, we double-stained the CHO cells with an antibody to the ER-located protein grp78 (BiP) (Fig. 2B) , which resulted in a highly similar staining pattern. An almost complete colocalization was observed for PS proteins and grp78 (BiP) after superimposing the images obtained in Fig. 2 A and B (Fig. 2C) . To prove the specificity of the observed staining pattern, antibody TOR519 was preabsorbed with the corresponding peptide antigen. Preabsorption clearly abolished the ER staining (compare Fig. 2 D and E). No staining was observed as well, when secondary antibodies were used as a negative control (Fig. 2F) . Moreover, the independent antibody BOS4627 to the C terminus of PS-1 also stained the ER (data not shown). These results therefore indicate that endogenous PS proteins are localized predominantly within the ER.
To prove the subcellular localization of PS proteins more precisely, PS-1 as well as PS-2 proteins were overexpressed in COS-7 cells. PS-1 was observed by immunostaining with antibody BOS4627 within a network throughout the cytoplasm, which colocalized with the ER marker grp78 (BiP) ( Fig. 3 A and B ). Since the experiments were carried out with transiently transfected cells, a large number of untransfected cells were observed, which were stained very weakly, showing the specifity of the antibody used. In order to prove if PS proteins can also be detected within Golgi compartments, PS-1-transfected cells were double stained with a PS antibody and an antibody to the Golgi protein p58. Indeed, PS-1 could be detected within the Golgi stack as indicated by costaining of antibody BOS4627 to PS-1 and the antibody to the Golgi protein p58 ( Fig. 3 C and D ). However, it should be noted that the majority of PS-1 proteins are localized in the ER, which is out of focus in Fig. 3 C and D.
Since PAPP is predominantly located within the Golgi (37) we proved a potential colocalization of PS-1 and,APP. COS-7 cells, double-transfected with the PAPP and PS-1 cDNA, were doublestained with BOS4627 and the monoclonal antibody 5A3/iG7 to /APP (38) . As shown in Fig. 3 E and F, colocalization of PS-1 and f3APP could be observed. Interestingly, the colocalization was restricted to the Golgi, the predominant subcellular localization of 13APP (37), whereas very little costaining was observed within the ER. This suggests that PS proteins, in contrast to ,3APP, are probably actively retained within the ER. Moreover, since f3APP is detected at its expected subcellular localization, overexpression of PS-1 is unlikely to result in an artificial protein retention within the ER. If that would be the case 3APP should also be retained and predominantly locate within the ER, which was not observed. Data similar to those shown in Fig. 3 (Fig. 4C) . Again, full-length PS-2 was also detected in the Golgi as shown by costaining with WGA (Fig. 4 D and E) . Interestingly, the C-terminal deleted form of PS-2 ending after TM4 shows a similar staining pattern like full-length PS-2 ( Fig. 4 F-K (Fig. 5C ), indicating that glycosylation of ,BAPP was indeed inhibited by tunicamycin treatment. In addition, immunoprecipitated PS proteins from cell lysates and APPS from conditioned media were incubated with N-glycosidase F. No molecular weight shift was observed for either PS-I or PS-2, while APPS showed the expected reduction of the molecular weight after N-glycosidase F treatment (40) (Fig. 5D ). These data therefore indicate that PS proteins do not undergo N-linked glycosylation.
FIG. 3. Subcellular localization of overexpressed PS-1 in COS-7 cells
COS-7 cells were transfected with the PS-I cDNA and co-stained with antibody BOS4627 (A, PS-1) and a monoclonal antibody to grp78 (BiP), labeling the ER (B, ER). The majority of PS-1 staining was observed within the ER as indicated by the overlapping staining of antibody BOS4627 and the antibody to grp78 (BiP). (C and D). COS-7 cells transfected with the PS-I cDNA were costained with B0S4627 (C, PS-1) and a monoclonal antibody to p58 (D, Golgi) which is located within the Golgi. Overlapping expression of p58 and PS-I is observed to some extend within the Golgi. Note that the photograph was taken by focusing on the Golgi. The predominant ER staining with antibody BOS4627 is out of focus. (E and F) Colocalization of PS-I and ,BAPP. COS-7 cells were double transfected the PS-I cDNA and the f3APP cDNA CMV695 (38) and stained with BOS4627 (E, PS-1) and the monoclonal antibody 5A3/1 G7 to f3APP (F, ,BAPP [17] ) and with the PS-2 cDNA containing the Asnl4llle mutation found in the Volga German kindred (18, 19) . As shown for wildtype PS-2, the Asnl41Ile mutation is strongly phosphorylated, whereas very little phophorylation for the Ala246Glu mutation (PS-1) was observed (Fig. 6B ).
To determine which amino acids of the PS-2 proteins are modified by protein phosphorylation, phosphoamino acid analysis of in vivo phosphorylated PS-2 proteins was performed. As shown in Fig. 6C Identification of the in Vivo Phosphorylation Sites of PS-2 In order to identify the phosphorylated domain of the PS-2 protein, we introduced serial deletions by inserting stop codons after TM7, TM6, TM5, and TM4 as described in Fig. 4 (Fig. 8A) . Interestingly, the truncated PS-2 proteins were consistently detected as closely spaced triplet bands. Labeling with [32P] -orthophosphate still resulted in the detection of the corresponding phosphorylated recombinant proteins (Fig. 8A) . Of the three observed polypeptides labeled with [35S]-methionine, only the two higher bands were phosphorylated (Fig. 8A) . The observed molecular weight difference between the three polypeptides is very little, which might explain why these triplets can not be observed after expressing the wildtype PS-2 cDNA or the PS-2TM7 cDNA construct.
It is important to note that the corresponding truncated PS-I proteins migrate as single bands (Fig. ID) (Fig. 9 B and C) . In contrast, phosphate incorporation into full-length PS-2 protein carrying the double mutation (Ser 7, 9 Ala) was reduced only by approximately 60% (Fig. 9 B and C) . These data strongly suggest that the three serine residues (Ser 7, Ser 9, and Ser 19) represent phosphorylation sites in vivo. Mutagenesis of serines 7 and 9 to alanine removes only two phosphor acceptor sites therefore resulting in the reduction of two-thirds of phosphate incorporation. To Despite the similarities between PS-1 and PS-2 concerning their subcellular localization and their lack of sulfation and glycosylation, we were able to demonstrate a striking difference between the two proteins in regard to phosphorylation. In vivo labeling with [32P] -orthophosphate revealed a significant phosphorylation of PS-2 on serine residues, while very little phosphate incorporation was observed for PS-1. It was reported that potential PKC recognition sequences are present within the PS amino acid sequence (17) . PKC-dependent phosphorylation of the PS proteins would be very interesting, because this could provide a direct link to PKCdependent regulation of ,3APP processing and A,B generation. Upon PKC stimulation, a-secretory processing of ,BAPP is strongly increased (42, 45) , whereas A,B production is significantly reduced (35, 46) . However, the data presented here disfavor a direct phosphorylation of the native PS proteins by PKC, because stimulation of PKC with the phorbol ester PDBu as well as selective PKC inhibition had no influence on PS-2 phosphorylation.
Using C-terminal deleted forms of PS-2, and hybrid molecules of PS-I and PS-2, the selective phosphorylation of PS-2 was mapped to its N terminus. Although highly homologous throughout the whole amino acid sequence, the N termini of PS-1 and PS-2 show significant differences. Especially, the first 20 amino acids of PS-2 include a cluster of acidic residues, which is absent in PS-1. This acidic stretch contains two potential phosphorylation sites for CK-2 (Ser7 and Ser9) and one for CK-1 (Serl9). By investigating the phosphorylation of PS-2 proteins lacking the acidic stretch or carrying point mutations where serine residues are substituted by alanine residues we showed that serines 7, 9, and 19 are phosphorylated in vivo. In addition, we demonstrated that GST-fusionproteins carrying the PS-2 N terminus can be phosphorylated in vitro by both CKI-1 and CK-2. These results strongly suggest a modification of PS-2 by these protein kinases in vivo. Mapping of PS-2 phosphorylation to its N terminus also gives hinds to the topology of PS proteins. Since CK-1 and CK-2 are known to be localized in the cytoplasm (47, 48) , the N terminus of PS-2 and, consequently, that of PS-I are likely to be directed toward the cytoplasmic face of the ER. Assuming a seven transmembrane structure of PS proteins, the large hydrophilic loop should be exposed to the cytoplasm as well. However, this model clearly requires further confirmation.
The functional consequences of PS-2 phosphorylation are unknown so far. It has been reported recently that furin, a transmembrane serine protease is phosphorylated in its cytoplasmic domain by a CK-2 activity associated with the rough ER (49) . CK-2-mediated phosphorylation was shown to modulate the subcellular localization of furin. Whether the phosphorylation or dephosphorylation of PS-2 results in alterations of PS-2 function or localization remains to be determined. However, based on light microscopy no differences in the localization of phosphorylated and unphosphorylated PS-2 were found. The involvement of two different protein kinases, phosphorylating PS-2 at distinct amino acids provides a mechanism for a highly controlled and fine-tuned regulation. Whether the specific phosphorylation of PS-2 in an acidic N-terminal sequence, which is absent in PS-1, determines different biological functions of the two highly homologous PS proteins will also be of great interest. 
